What the study found: Symptom-based dosing for infants with neonatal opioid withdrawal syndrome (NOWS) led to a shorter time to medical readiness for discharge than a scheduled opioid taper among infants cared for with Eat, Sleep, Console (ESC), a care approach that focuses on whether infants can eat, sleep, and be consoled.
Why the authors say this matters: The authors conclude that symptom-based dosing may better align opioid treatment with withdrawal severity, and the findings indicate it reduced time to medical readiness for discharge in the ESC setting.
What the researchers tested: In a cluster crossover randomized clinical trial at 23 US hospitals, infants at least 36 weeks' gestation and at risk for pharmacologic treatment were assigned to symptom-based dosing or scheduled opioid taper, using site-specific opioid algorithms. Hospitals used either ESC or Finnegan-based care, a symptom scoring system for withdrawal severity, and each site used its preferred primary opioid.
What worked and what didn't: In the ESC cohort, time to medical readiness for discharge was shorter with symptom-based dosing than with scheduled taper (9.18 vs 11.61 days; adjusted mean ratio 0.79). There was no difference in initiation of pharmacologic treatment or length of stay, and 35% of infants in the symptom-based group still needed scheduled opioid dosing because intermittent dosing did not control withdrawal severity. In the Finnegan cohort, there were no significant differences in time to medical readiness for discharge or length of stay.
What to keep in mind: The abstract reports that the inpatient composite safety outcome occurred rarely, but it does not provide a fuller safety discussion here. The main positive finding was reported for infants cared for with ESC, while the Finnegan cohort did not show significant differences.
Key points
- Symptom-based dosing shortened time to medical readiness for discharge in infants cared for with ESC.
- In the ESC cohort, readiness for discharge was 9.18 days with symptom-based dosing versus 11.61 days with scheduled taper.
- There was no difference in starting pharmacologic treatment or in length of stay in the ESC cohort.
- Thirty-five percent of infants in the symptom-based group needed scheduled opioid dosing because intermittent dosing was not enough.
- In the Finnegan cohort, there were no significant differences in readiness for discharge or length of stay.
Disclosure
- Research title:
- Symptom-based dosing shortened discharge readiness time in NOWS
- Authors:
- Lori A. Devlin, Denise C. Babineau, Stephanie L. Merhar, Sara B. DeMauro, Walter K. Kraft, Scott A. Lorch, Abhik Das, Scott A. McDonald, E. Leeon Rhodes, Augusto F. Schmidt, Lillian Trochinski, Margaret Crawford, Thitinart Sithisarn, Lawrence Leeman, Kelley Kovatis, Namasivayam Ambalavanan, Ryan Smith, Sucheta Telang, Jennifer A. Tioseco, Jennifer M. McAllister, Scott L. Wexelblatt, Bhanu Muniyappa, Patricia K. Williams, Susan Adeniyi-Jones, Crystal D. Hill, Tanner Wright, Gregory M. Sokol, Lynette Johnson, Richard W. Hall, Scott D. Duncan, Karen Puopolo, Krishna Dummula, Ann Anderson-Berry, Jonathan M. Davis, Brenda Poindexter, Leslie W. Young, Crystal Bass, Elizabeth Hendricks, David Paul, Jennifer Chambers, Amy Mackley, Ward Rice, Cathy Grisby, David Russell, Lisa Tully, Traci Beiersdorfer, Carla King, Cynthia Reid, Stephanie Wilson Archer, Henrietta Bada, Mina Hanna, Amanda Wilburn, Susan DeGraaff, Beth McKinney-Whitlock, Carrie Hobbs, Crystal Wilson, Anna E. Thomas, Hannah Rakow, Jessica Mendoza, Betsy Tudor, Loren Nallu, Mary Connolly, Allison Dymacek, Karen Herzing, Natalie Goodman, Erin Bohon, Aprill Shockley, Emily Smith, Jenny Auman, Anna Mazur, Shannon Barnes, Brittany Thomas, Eugene Turner, James Pickett, D Leblond, Savannah Moore, Courtenay Fulmor, Lisa Pullaro, Emily J. Murray, Megan Lennon Kundrat, Angela Pallotto, Melette Pearson, Myriam Peralta-Carcelen, Waldemar A. Carlo, Samuel Gentle, Sandra Turner, Rachel Benz, Sharon Owen, Vallon Williams, Allyson Cheathem, A. Keyes, Kristina Foster, Allison Scott, Madison Jessie, Sarah Morris, Jennifer Nason, Audrey Miller, Rachel Welch-Miles, Molly Hemmerle, Betty Oberle, Matt VanOrmer, Sarah Newman, Emilee Kendall, Kym Abraham, Sofia M Markee, Nicole Yonke, Jessie Maxwell, Sandra Beauman, Conra Lacy, Ashley Palmer, Elizabeth Kuan, Megan Dhawan, Mary Catherine Gambacorta, Jon Snyder, Melanie Risch, Hanna Rosewood, Ronnie Guillet, Julie Riccio, Melissa Moreland, Rachel Jones, Marcia Kneusel, Courtney Casey, Robin K. Ohls, Camille Fung, Carrie A. Rau, Kathie Coleman, Kandace M. McGrath, Manndi C. Loertscher
- Institutions:
- University of Louisville, RTI International, RTI Health Solutions, Cincinnati Children's Hospital Medical Center, Good Samaritan Hospital, St. Elizabeth Healthcare, Perinatal Institute, Children's Hospital of Philadelphia, University of Pennsylvania, Thomas Jefferson University, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Golisano Children's Hospital, University of New Mexico, Christiana Care Health System, University of Alabama at Birmingham, Norton Women's and Children's Hospital, Norton Hospital, AtlantiCare, University of Utah, Children's Hospital of Oklahoma, University of Oklahoma Health Sciences Center, University of South Florida, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis, University of Rochester, University of Arkansas for Medical Sciences, University of Louisville Hospital, Children's Mercy Hospital, Mercy Hospital, University of Kansas Medical Center, University of Nebraska Medical Center, Tufts Medical Center, Emory University, University of Vermont, Roshydromet
- Publication date:
- 2026-04-25
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with peer-reviewed research without reading academic papers — one filtered digest, every Friday.